| Model Number |
D-EVOLUTFX-2329 |
| Medical Device Problem Code |
Patient Device Interaction Problem (4001)
|
| Health Effect - Clinical Codes |
Hemorrhage/Blood Loss/Bleeding (1888); Pseudoaneurysm (2605); Ruptured Aneurysm (4436)
|
| Date of Event |
03/31/2026
|
|
Type of Reportable Event
|
Death
|
|
Additional Manufacturer Narrative
|
|
Continuation of d10: product id: evfxplus-23 (serial: unknown); product type: 0195-heart valves; implant date: on (b)(6) 2026; explant date: n/a.Select patient information cannot be included in the regulatory report due to regional privacy regulations.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that 3 months following implantation of a transcatheter aortic valve, the patient died due to exsanguination from the rupture of a femoral artery pseudoaneurysm.Per the physician, the procedure contributed to the patient's death.
|
| |
|
Search Alerts/Recalls
|